Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction
Fihlman, Mari, Hemmilä, Tuija, Hagelberg, Nora M., Kuusniemi, Kristiina, Backman, Janne T., Laitila, Jouko, Laine, Kari, Neuvonen, Pertti J., Olkkola, Klaus T., Saari, Teijo I.Volume:
72
Language:
english
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-016-2109-y
Date:
November, 2016
File:
PDF, 381 KB
english, 2016